Molecular Biomarkers & Diagnosis

Transient Myeloproliferative Disorder in Neonate with Suspected Down Syndrome

Abstract

Brianne Weber, Patricia Tille*

A female with suspected Down syndrome was born by vaginal delivery at 37 weeks 2 days’ gestation to a mother with a history of Type A2 gestational diabetes mellitus. Routine prenatal testing consisted of a non-invasive screening test for aneuploidy. Results, presented in Table 1, indicated an aneuploidy for trisomy of chromosome 21, indicating an increased risk for Down syndrome.